STANDING TOGETHER WITH PATIENTS
LIVE

Serial Number

79425959

Owner

ONO PHARMACEUTICAL CO., LTD.

Attorney

Leigh Ann Lindquist

Filing Date

Oct 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

STANDING TOGETHER WITH PATIENTS Trademark

Serial Number: 79425959 • Registration: 8248647

STANDING TOGETHER WITH PATIENTS is a trademark filed by ONO PHARMACEUTICAL CO., LTD. on October 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ONO PHARMACEUTICAL CO., LTD.

1-5, Doshomachi 2-chome,

Entity Type: 03

Trademark Details

Filing Date

October 8, 2024

Registration Date

May 12, 2026

Published for Opposition

March 24, 2026

Goods & Services

Provision of medical and pharmaceutical information via the Internet; provision of medical information relating to benefits, side effects, interactions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medical, medicinal and pharmaceutical consultancy; Medical and pharmaceutical consultation, namely, advisory services in the field of pharmaceutical products; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical information, analysis and provision of medical information for diagnostic or treatment purposes; medical testing; Consultancy in the field of the medical diagnosis of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications via the Internet; online medical counseling services; Remote monitoring of medical data for medical diagnosis and treatment, namely, remote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; providing medical information; physical examination services; Providing medical information, namely, information about pharmaceuticals, medical services and health; Medical consultancy relating to medical services, pharmaceuticals, health and dispensing of medications; Medical consultancy, advisory and provision of information relating to dieting, nutritional intake and health care; Medical consultancy, advisory and provision of information relating to health care; managed health care services; Providing health information, namely, provision of records of personal health information data such as weight, body fat, body temperature, number of steps, sleeping hours and blood pressure; Medical nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; nursing care; rental of medical apparatus and instruments

Pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powders, pills, capsules, granules, jellies or liquids; dietary supplements for human beings; dietary fiber to aid digestion; lyophilised food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 12, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 12, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 12, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Mar 19, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2025 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 11, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 11, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 11, 2025 COAR
REFUSAL PROCESSED BY IB
Oct 10, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 13, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 12, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 25, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 24, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 24, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR